| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MNFR.201200651 |
| P8608 | Fatcat ID | release_oslzfpcn5jfnderqrzujl6y7y4 |
| P698 | PubMed publication ID | 23417986 |
| P50 | author | Hai-Shu Lin | Q84929621 |
| P2093 | author name string | Paul C Ho | |
| Samuel Chao Ming Yeo | |||
| P2860 | cites work | Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats | Q24597042 |
| Cancer statistics, 2012 | Q27860574 | ||
| Therapeutic potential of resveratrol: the in vivo evidence | Q29547413 | ||
| Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study | Q33458540 | ||
| Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats | Q33974480 | ||
| Resveratrol bioavailability and toxicity in humans | Q34020588 | ||
| 13-cis-retinoic acid in the treatment of oral leukoplakia | Q34182878 | ||
| Pterostilbene-induced tumor cytotoxicity: a lysosomal membrane permeabilization-dependent mechanism | Q34408186 | ||
| Effect of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin- and nicotinamide-induced diabetic rats | Q34514218 | ||
| Cyclodextrin-based pharmaceutics: past, present and future | Q34552997 | ||
| Inhibition of human recombinant cytochromes P450 CYP1A1 and CYP1B1 by trans-resveratrol methyl ethers. | Q34578761 | ||
| Oral cancer prevention and control--the approach of the World Health Organization | Q34597352 | ||
| Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging | Q34599350 | ||
| Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity | Q34668236 | ||
| Antihyperglycemic activity of phenolics from Pterocarpus marsupium | Q34741553 | ||
| Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression. | Q34776442 | ||
| Inhibitory effects of resveratrol and pterostilbene on human colon cancer cells: a side-by-side comparison | Q35445753 | ||
| Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity | Q35832689 | ||
| Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor | Q36086859 | ||
| Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans | Q36909306 | ||
| Quantification of trans-2,6-difluoro-4'-N,N-dimethylaminostilbene in rat plasma: application to a pharmacokinetic study | Q37063698 | ||
| Pharmacometrics of stilbenes: seguing towards the clinic. | Q37230223 | ||
| Biological/chemopreventive activity of stilbenes and their effect on colon cancer | Q37289912 | ||
| Resveratrol and health--a comprehensive review of human clinical trials | Q37891928 | ||
| Molecular mechanisms for anti-aging by natural dietary compounds. | Q37956231 | ||
| Pterostilbene and cancer: current review | Q37958292 | ||
| Resveratrol in human cancer chemoprevention--choosing the 'right' dose. | Q37973282 | ||
| Antihyperuricemic and nephroprotective effects of resveratrol and its analogues in hyperuricemic mice | Q38322940 | ||
| Chemopreventive effects of pterostilbene on urethane-induced lung carcinogenesis in mice via the inhibition of EGFR-mediated pathways and the induction of apoptosis and autophagy | Q39251116 | ||
| Pterostilbene ameliorates tumor necrosis factor alpha-induced pancreatitis in vitro. | Q39284253 | ||
| Pterostilbene suppresses benzo[a]pyrene-induced airway remodeling | Q39524144 | ||
| Determination of trans-2,4,3',4',5'-pentamethoxystilbene in rat plasma and its application to a pharmacokinetic study. | Q39708919 | ||
| In vitro evaluation of the cytotoxic, anti-proliferative and anti-oxidant properties of pterostilbene isolated from Pterocarpus marsupium | Q39740180 | ||
| Pterostilbene from Vitis coignetiae protect H2O2-induced inhibition of gap junctional intercellular communication in rat liver cell line | Q39902648 | ||
| Pterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. | Q39957137 | ||
| Pterostilbene, a natural analogue of resveratrol, potently inhibits 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin carcinogenesis | Q42716719 | ||
| Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway | Q42748324 | ||
| Inhibitory effects of garcinol and pterostilbene on cell proliferation and adipogenesis in 3T3-L1 cells | Q42803142 | ||
| Pterostilbene inhibits colorectal aberrant crypt foci (ACF) and colon carcinogenesis via suppression of multiple signal transduction pathways in azoxymethane-treated mice | Q42948195 | ||
| Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells | Q43758223 | ||
| Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol | Q44008461 | ||
| Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate | Q44010079 | ||
| Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. | Q46085613 | ||
| Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters | Q46456798 | ||
| The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol | Q46482181 | ||
| Effects of resveratrol and its derivatives on lipopolysaccharide-induced microglial activation and their structure-activity relationships | Q46566686 | ||
| Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease | Q48856453 | ||
| Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability. | Q51374512 | ||
| The antioxidant role of pterostilbene in streptozotocin-nicotinamide-induced type 2 diabetes mellitus in Wistar rats. | Q51484569 | ||
| Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats. | Q53338338 | ||
| Pterostilbene, a natural small-molecular compound, promotes cytoprotective macroautophagy in vascular endothelial cells. | Q54490390 | ||
| Pterostilbene protects vascular endothelial cells against oxidized low-density lipoprotein-induced apoptosis in vitro and in vivo | Q57246979 | ||
| P433 | issue | 6 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| bioavailability | Q461809 | ||
| P304 | page(s) | 1015-1025 | |
| P577 | publication date | 2013-02-18 | |
| P1433 | published in | Molecular Nutrition and Food Research | Q15751861 |
| P1476 | title | Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability | |
| P478 | volume | 57 |
| Q89883952 | An Open-Label Single-Arm, Monocentric Study Assessing the Efficacy and Safety of Natural Pterostilbene (Pterocarpus marsupium) for Skin Brightening and Antiaging Effects |
| Q46692307 | Analysis of trans-2,6-difluoro-4'-(N,N-dimethylamino)stilbene (DFS) in biological samples by liquid chromatography-tandem mass spectrometry: metabolite identification and pharmacokinetics |
| Q89964362 | Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review |
| Q48152957 | Chemoprevention by resveratrol and pterostilbene: Targeting on epigenetic regulation |
| Q96231499 | Comparison of the protective effects of resveratrol and pterostilbene against intestinal damage and redox imbalance in weanling piglets |
| Q49499256 | Determination of Tangeretin in Rat Plasma: Assessment of Its Clearance and Absolute Oral Bioavailability |
| Q53496604 | Determination of naturally occurring resveratrol analog trans-4,4'-dihydroxystilbene in rat plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study. |
| Q42049687 | Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer |
| Q64284363 | Effect of pterostilbene on drug metabolizing enzyme activity |
| Q38262965 | Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution? |
| Q38848934 | Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer |
| Q47930405 | Isorhapontigenin, a bioavailable dietary polyphenol, suppresses airway epithelial cell inflammation through a corticosteroid-independent mechanism. |
| Q47189418 | Metabolism and pharmacokinetics of resveratrol and pterostilbene |
| Q48264387 | Oral delivery system enhanced the bioavailability of stilbenes: Resveratrol and pterostilbene |
| Q36566678 | Pharmacokinetic/Toxicity Properties of the New Anti-Staphylococcal Lead Compound SK-03-92. |
| Q46863513 | Pharmacokinetics and tissue distribution of pterostilbene in the rat. |
| Q40144743 | Potent Inhibition of HIV-1 Replication in Resting CD4 T Cells by Resveratrol and Pterostilbene |
| Q90533040 | Pre-clinical Pharmacokinetic and Metabolomic Analyses of Isorhapontigenin, a Dietary Resveratrol Derivative |
| Q90438421 | Profile of pterostilbene-induced redox homeostasis modulation in cardiac myoblasts and heart tissue |
| Q60935435 | Pterostilbene Attenuates Hexavalent Chromium-Induced Allergic Contact Dermatitis by Preventing Cell Apoptosis and Inhibiting IL-1β-Related NLRP3 Inflammasome Activation |
| Q96131891 | Pterostilbene complexed with cyclodextrin exerts antimicrobial and anti-inflammatory effects |
| Q53704091 | Pterostilbene modulates the suppression of multidrug resistance protein 1 and triggers autophagic and apoptotic mechanisms in cisplatin-resistant human oral cancer CAR cells via AKT signaling. |
| Q46362372 | Pterostilbene protects against UVB-induced photo-damage through a phosphatidylinositol-3-kinase-dependent Nrf2/ARE pathway in human keratinocytes |
| Q48133911 | Pterostilbene reduces oxidative stress, prevents hypertrophy and preserves systolic function of right ventricle in cor pulmonale model |
| Q46523185 | Pterostilbene-induced changes in gut microbiota composition in relation to obesity. |
| Q38702262 | Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer |
| Q64984529 | Resveratrol and pterostilbene attenuated smokeless tobacco induced cardiovascular aberrations in estrogen deficient female rats. |
| Q38839803 | Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer |
| Q41551014 | Resveratrol enhances polyubiquitination-mediated ARV7 degradation in prostate cancer cells. |
| Q58756915 | Resveratrol: A Double-Edged Sword in Health Benefits |
| Q26769976 | Role of Natural Stilbenes in the Prevention of Cancer |
| Q89124590 | Synthesis and antitumor activity of bis(hydroxymethyl)propionate analogs of pterostilbene in cisplatin-resistant human oral cancer cells |
| Q43563450 | Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression |
| Q42082066 | The effects of pterostilbene on neutrophil activity in experimental model of arthritis |
| Q55251964 | Therapeutic Potential of Pterostilbene and Resveratrol on Biomechanic, Biochemical, and Histological Parameters in Streptozotocin-Induced Diabetic Rats. |
| Q50869850 | Toward Resolving the Resveratrol Conundrum: Synthesis and in Vivo Pharmacokinetic Evaluation of BCP-Resveratrol. |
Search more.